Mr. Rami Levi, Founder and President of Catalyst Group International, brings over 30 years of experience in managing successful international projects on five continents, partnering with world leaders, and connecting nations and industry on a global scale. His career, spanning both the public and private sectors, has included five diplomatic missions on behalf of the State of Israel, as well as the founding of several successful companies. A leading expert in international affairs, global market development, crisis management, strategic planning and government regulatory management, Mr. Levi has generated and managed major cross countries agreements over the years.   As Senior Deputy General & Head of Marketing Administration at Israel’s Ministry of Tourism, Mr. Levi led numerous international initiatives and global partnerships involving 42 governments and world-leading conglomerates. In the private sector, he founded Catalyst Group, working as a consultant for governments, global law firms, banks, television networks and multinational NGOs. Mr. Levi’s holds an MA with Honors in Political Science from The Hebrew University of Jerusalem.

Ms. Maital Shemesh-Rasmussen brings over 20 years of diverse commercialization experience across various industries. Driving growth in the health-tech sector, she has specifically focused on personalized care and patient-centric, data-driven products and value-based approaches. From 2018 to 2020, she served as Global Head of Solution Marketing at Roche Diagnostics Information Solutions, where she defined Roche’s new health-tech strategy, bringing to market advanced digital solutions and commercial models that positioned Roche as a world leader in health technology. Key positions previously held by Ms. Shemesh-Rasmussen include: Director of Strategic and Product Marketing at Oracle Healthcare and Precision Medicine (2013-2016), where she drove penetration of the informatics, analytics and precision medicine market; Vice President of Global Marketing at JPMorgan Chase Bank (2002-2007), where she led global marketing and technology innovation to generate multimillion-dollar growth; Founder & CEO of Rasmussen Communications marketing agency, where she shaped marketing strategies and messaging for financial, health and technology firms; a consultant for startups; and a Board Member/Marketing Chair of Healthcare Information and Management Systems Society Northern California. Her education includes a BA in Behavioral Sciences, Magna Cum Laude, from Ben-Gurion University of the Negev, studies for an MA in Political Science and Communication at Bar-Ilan University, and the Executive Education Program in Strategy, Finance and Computer Science at Columbia University, New York.

Mr. Doron Birger is a high-tech industry executive with a background in bringing groundbreaking products to market.  He has more than 30 years of experience in the Israeli high-tech sector as a chief executive officer, board chairman, director, and advisor to several private and publicly traded firms, with an emphasis in the life science industry.  Key positions previously held by Mr. Birger include: president and Chief Executive Officer of Elron (Nasdaq, TASE: ELRNF) (2002-2009), Chairman of the Board at Given Imaging (2002-2007), and a director until it was sold to Covidien in 2014. Mr. Birger was also the Chief Financial Officer at several companies from various sectors (1978-2001), including the CFO of Elron (1994-2001). Mr Birger currently chairs several technology companies, including Sight Diagnostic, Ultrasight, Nurami, Matricelf (TASE: MTLF), and Intelicanna (TASE: INTL). He is also a director in a variety of medical device and advanced technology companies, including IceCure (TASE: ICCM), Citrine Global (OTCQB: CTGL), Kadimastem (TASE: KDST), HeraMED (ASX: HMD) Vibrant, and Netive Haor. Mr. Birger earned his bachelor’s degree and Master of Economics from the Hebrew University, Jerusalem.

Mr. Yaky Yanay was appointed as CEO from June 2019 after serving as President from February 2014.  Mr. Yanay served in variety of executive positions in Pluri since 2006 including Co-CEO, Chief Financial Officer, Chief Operating Officer and Executive Vice President. Mr. Yanay is the former Co-Chairman and current board member of Israel Advanced Technology Industries (IATI), the largest umbrella organization representing Israel’s life science and high-tech industries. Mr. Yanay founded over the years several activities and organizations to promote and support the Israeli life science industry. Before joining Pluri, Mr. Yanay was the Chief Financial Officer of Elbit Vision Systems Ltd. a public, machine vision, high-tech company. Prior to that Mr. Yanay served as manager at Ernst & Young Israel. Mr. Yanay holds a bachelor’s degree with honors in business administration and accounting and is a Certified Public Accountant in Israel.

Mr. Zami Aberman is Chairman of the Board. He joined Pluri in September 2005, and redirected the Company’s strategy towards cellular therapeutics to become one of the global leaders in the industry. Mr. Aberman’s vision to use the maternal portion of the placenta as a cell source for Pluri’s products, combined with Pluri’s 3D culturing technology, led to the development of the Company’s unique therapies. In 2013 the World Stem Cells Regenerative Medicine Congress ranked Mr. Aberman as one of the 50 most influential people in the stem cells space. Prior to Pluri, Mr. Aberman had a 30-year career as a senior executive in the high-tech industry with multiple companies in Israel, the U.S., Europe, Japan and Korea. Previous roles include Chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP; Director of Ori Software Ltd., a company involved in data management; President and CEO of Elbit Vision Systems (EVSNF.OB), which supplies inspection systems for the microelectronics industry; President and CEO of Netect Ltd., a company specializing in the field of internet security software; Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing; Chairman of Display Inspection Systems Inc., a company specializing in laser based inspection machines; and President and CEO of Robomatix Technologies Ltd. (RBMXF.OB). In addition to his current role at Pluri, Mr. Aberman serves as the Chairman of Rose Hitech Ltd., a private investment company in 1992, Mr. Aberman was awarded the Rothschild Prize for excellence in his field from the President of the State of Israel. Mr. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.